Table 1

Incubation and analysis conditions to determine IC50 values in vitro in human liver microsomes for trans-(±)-2-phenylcyclopropylamine (tranylcypromine) and cyclopropylbenzene in seven CYP-specific activities

CYPSubstrate, Conc. in IncubationProteinCofactor SystemIncubation TimeDetermination, λHPLC Conditions
mg/ml min nm
CYP1A2Ethoxyresorufin, 1 μM0.1NADPH-regenerating 5Fluorometric, ex 530, em 585
CYP2A6Coumarin, 10 μM0.2NADPH-regenerating10Fluorometric, ex 395, em 454
CYP2C9Tolbutamide, 200 μM0.75NADPH-regenerating20UV-HPLC, 236Column: Symmetry C18 3.9 × 150 mm, 5-μm (Waters Co.)
CYP2C19 rac-Mephenytoin, 100 μM0.5NADPH20UV-HPLC, 204/240Flow: 1.0 ml/min
CYP2D6Dextromethorphan, 100 μM0.5NADPH-regenerating20UV-HPLC, 204/280Eluent: CYP2C19: 50 mM H3PO4, pH 7.0 + acetonitrile (75:25); CYP2C9, CYP2E1: 50 mM
CYP2E1Chlorzoxazone, 100 μM0.5NADPH-regenerating20UV-HPLC, 282H3PO4, pH 3.0 + acetonitrile (70:30); CYP2D6: 50 mM H3PO4, pH 3.0 + acetonitrile (75:25); CYP3A4: 40% acetonitrile
CYP3A4/5Midazolam, 10 μM0.5NADPH10UV-HPLC, 245
  • ex, excitation; em, emission.